The fact that the drug belongs to the indirect coagulants, it was available to vikasol instructions for use: if uterine bleeding it is used as part of a treatment or for medical emergencies in difficult cases.
The composition and action
The drug has a pharmacological action because it is an active component of menadione sodium bisulfite. The amount of this substance in the composition of the drug depends on the shape vikasol release;
- Tablets - 15 mg each;
- vials - 10 mg per 1 ml of solution for injection.
The tablets are packed into blisters of 10 and 20 pieces. The solution is filled into ampoules of 1-2 ml. Packages may contain from 10 to 100 vials.
The drug belongs to a group of antihemorrhagic drugs. Due to the hemostatic properties used in the bleeding of various origins. Vikasol stimulates reductase enzyme (vitamin K3), which leads to improved blood coagulability.
Indications and contraindications
Uterine bleeding (menorrhagia) - pathological process, requiring further mandatory diagnosis and treatment. A survey conducted after the termination of bleeding, which helps to cope with the reception of menadione.
The drug is indicated in the following cases:
- menstrual disorders caused by hormonal failure, the cause of which are endocrine diseases;
- heavy bleeding, accompanied by some gynecological diseases in which the mucous the endometrium undergoes hypertrophy, resulting in a large rejected during menstruation amount of tissue;
- a lack of vitamin K, which is causing problems with blood clotting;
- menorrhagia, ie bleeding of unknown origin;
- insufficient uterine contractions.
This drug is not allowed to take everything. Vikasol contraindicated in people who have had high blood clotting. Not prescribers with a propensity to a number of diseases: hypercoagulable state, thrombosis, thromboembolism. In women suffering from renal disease, Vikasol causes side effects, and the drug is not assigned to them.
The drug is not recommended for individual intolerance substances present in the composition of tablets and solution. When the unpleasant symptoms of an allergic reaction after drug administration should be as soon as possible to appeal to the doctor
How to make bleedings
Vikasol treatment for uterine bleeding is carried out under medical supervision. Selection using the method (injection or oral) depends on the condition of the patient and the doctor is also determined.
The drug is possible in two ways:
- for the early stop menorrhagia, life-threatening;
- in the complex therapy of gynecological diseases accompanied by intense bleeding from the genital tract.
In the first case, the doctor prescribes a solution for intramuscular administration. Injections act quickly, so they are used in an emergency. A single dose - 15 mg; fold - 2 times a day. The drug has a temporary effect, and for a complete treatment of patients hospitalized in medical facilities gynecology department.
Tablets are encouraged to take a part of complex treatment of bleeding from the genital tract, not threaten the patient's life. The daily dose (30 mg) was divided into 2-3 times. The course of treatment - 3-4 days, then a break of the same duration, after which the reception is repeated, if the doctor deems it necessary. Tablets take effect after 10-12 hours after administration.
Vikasol widely used in gynecological pathologies as considered an effective medication, stopping bleeding. But it can not be used independently.
